Clinical Trial Update: Assessment of Efficacy and Safety of 3 Different Doses of co.Don Chondrosphere to Treat Large Cartilage Defects [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed efficacy and safety of three doses of co.Don Chondrosphere for large articular cartilage lesions in the knee. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Defects of the Knee

Drugs mentioned

• co.Don Chondrosphere (autologous chondrocyte implantation product)

Snippet

Sponsor: co.don AG | Conditions: Large Articular Cartilage Lesions of the Femoral, Condyle, Trochlea, Tibia or Retropatellar | Phase 2 | Status: COMPLETED